{"id":"W3044295132","doi":"10.1001/jamaneurol.2020.2453","title":"Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis","year":2020,"lang":"en","type":"article","venue":"JAMA Neurology","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Notre-Dame; Centre Hospitalier de l’Université de Montréal","funders":"Sanofi Genzyme; EMD Serono; Ono Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Multiple Sclerosis Society of Canada; Canadian Institutes of Health Research; Teva Pharmaceutical Industries; Multiple Sclerosis Society; Biogen; Sanofi","keywords":"Multiple sclerosis; Medicine; Association (psychology); Immunotherapy; Active immunotherapy; Oncology; Internal medicine; Physical therapy; Psychology; Immunology; Psychotherapist","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001480639,0.0002316833,0.000416039,0.0006479933,0.0003016531,0.0005707178,0.0004126604,0.0004320747,0.001375045],"category_scores_gemma":[0.005648062,0.0001709078,0.0006317114,0.0008895743,0.0002291457,0.0005286401,0.0005050359,0.0008603209,0.0001274279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002577802,"about_ca_system_score_gemma":0.0004392959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001408422,"about_ca_topic_score_gemma":0.002142446,"domain_scores_codex":[0.9991356,0.0002343598,0.0001398675,0.0001799564,0.0001860691,0.0001242822],"domain_scores_gemma":[0.9935563,0.0009703383,0.004344369,0.0003460791,0.0003148182,0.0004680031],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002370029,0.00003083226,0.9982609,0.00001661719,0.00007873491,0.0000344394,0.00002005697,0.0000435636,0.00005541932,0.00001150571,0.00004933287,0.001161518],"study_design_scores_gemma":[0.00001552344,0.0001828149,0.9990006,0.00001054444,0.00004355553,0.0002033905,0.00004150995,0.0003151805,0.00003553682,0.00004587701,0.0001023682,0.000003091247],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998589,0.0005558092,0.0001015615,0.00009145031,0.000006791271,0.000006672999,0.0003901939,0.000003909282,0.0002546168],"genre_scores_gemma":[0.9993407,0.0001132868,0.00005653478,0.00001929717,0.00001859209,0.000007094428,0.0003723399,0.000001162405,0.00007103558],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001480639,"threshold_uncertainty_score":0.007830441,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02101196228268847,"score_gpt":0.2634625215192833,"score_spread":0.2424505592365948,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}